Efficacy and safety of 1% clascoterone cream through 12 weeks in patients ≥12 years of age with facial acne vulgaris

被引：0
|
作者：
Cartwright, Martina [1 ]
Moro, Luigi [2 ]
Fragasso, Enrico [2 ]
机构：
[1] Cassiopea Inc, San Diego, CA USA
[2] Cassiopea SpA, Lainate, Italy
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2022年 / 87卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
34781
引用
收藏
页码：AB49 / AB49
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of grazoprevir plus ribavirin for 12 or 24 weeks in treatment-naive patients with hepatitis C virus genotype 1 infection
    Gane, E.
    Ben Ari, Z.
    Mollison, L.
    Zuckerman, E.
    Bruck, R.
    Baruch, Y.
    Howe, A. Y. M.
    Wahl, J.
    Bhanja, S.
    Hwang, P.
    Zhao, Y.
    Robertson, M. N.
    JOURNAL OF VIRAL HEPATITIS, 2016, 23 (10) : 789 - 797
  • [42] Effectiveness of Wet Cupping on Patients with Facial Acne Vulgaris: A 12-Week, Randomized, Single-Blind, Intervention-Sham-Controlled Trial
    Tabatabaei, Fatemeh
    Pasalar, Mehdi
    Tajadini, Haleh
    Kamali, Mohadese
    Rampp, Thomas
    COMPLEMENTARY MEDICINE RESEARCH, 2021, 28 (06) : 508 - 515
  • [43] An open-label study investigating the efficacy and safety of 12-96 weeks of telmisartan treatment in patients with hypertension
    Ingino, C
    Farsang, C
    Laucevicius, A
    Bergovec, M
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2003, 31 (06) : 561 - 574
  • [44] An open label study to investigate the safety and efficacy of 12 weeks treatment with telmisartan in patients with mild-moderate hypertension
    Farsang, C
    Ingino, C
    Karpov, Y
    Laucevicius, A
    Mabayoje, MO
    O'Shaughnessy, D
    Dawson, M
    JOURNAL OF HYPERTENSION, 2003, 21 : S319 - S319
  • [45] A randomized placebo-controlled investigator-blinded face split study of 20% azelaic acid cream to evaluate the efficacy and safety in Japanese patients with acne vulgaris
    Hayashi, Nobukazu
    Koyanagi, Eriko
    Nogita, Tositatsu
    Fujiyama, Mika
    Kawashima, Makoto
    JOURNAL OF DERMATOLOGY, 2012, 39 : 249 - 250
  • [46] DUPILUMAB SIGNIFICANTLY IMPROVES CLINICAL EFFICACY IN PEDIATRIC ATOPIC DERMATITIS PATIENTS <12 YEARS OF AGE
    Katelaris, Constance
    Baselga, Eulalia
    Ramien, Michele
    Marcoux, Danielle
    de Graaf, Marlies
    Irvine, Alan
    Carvalho, Vania Oliveira
    Ardusso, Ledit R. F.
    Toledo-Bahena, Mirna
    Gupta, Rajan
    Tong, Thu
    Zhang, Annie
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 29 - 29
  • [47] Efficacy and safety of faricimab every 16 or 12 weeks for neovascular age-related macular degeneration: STAIRWAY phase 2 results
    Danzig, Carl
    Quezada, Carlos
    Basu, Karen
    Grzeschik, Susanna
    Sahni, Jayashree
    Silverman, David
    Osborne, Aaron
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [48] A Randomized, Multicenter, Double-Blind, Vehicle-Controlled Study Evaluating the Efficacy and Safety of Luliconazole Cream 1% Once Daily for 7 Days in Patients Aged ≥ 12 Years With Tinea Cruris
    Jones, Terry M.
    Jarratt, Michael T.
    Mendez-Moguel, Ines
    Paz, Nelly
    Grekin, Steven K.
    Smith, Christina Cognata
    Kaur, Mandeep
    JOURNAL OF DRUGS IN DERMATOLOGY, 2014, 13 (01) : 32 - 38
  • [49] Efficacy and Safety of an Aclidinium Bromide Treatment for 12 Weeks or Longer in Patients with Moderate-To-Severe COPD: A Meta-Analysis
    Zou, Yong
    Xiao, Jian
    Yang, Dan Hui
    Li, Jun
    Chen, Qiong
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 13 (04) : 499 - 508
  • [50] The Efficacy of 12 Weeks of Sofosbuvir, Daclatasvir, and Ribavirin in Treating Hepatitis C Patients with Cirrhosis, Genotypes 1 and 3
    Merat, Shahin
    Sharifi, Amir Houshang
    Haj-Sheykholeslami, Arghavan
    Poustchi, Hossein
    Fattahi, Babak
    Nateghi-Baygi, Alireza
    Alavian, Seyed Moayed
    Malekzadeh, Reza
    HEPATITIS MONTHLY, 2017, 17 (01) : 1 - 4
12345